Candida albicans Enables Staphylococcus aureus “Hitchhiking” Across Mucosa Original paper

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More

July 29, 2025

  • Microbes
    Microbes

    Microbes, short for microorganisms, are tiny living organisms that are ubiquitous in the environment, including on and inside the human body. They play a crucial role in human health and disease, functioning within complex ecosystems in various parts of the body, such as the skin, mouth, gut, and respiratory tract. The human microbiome, which is […]

  • Staphylococcus aureus (S. Aureus)
    Staphylococcus aureus (S. Aureus)

    Staphylococcus aureus is a versatile skin and mucosal commensal that can transition into a highly virulent pathobiont. Known for its immune-evasive strategies, toxin production, and antibiotic resistance, it plays a significant role in chronic infections and microbiome imbalance.

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More

Last Updated: 2025-07-29

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

What was studied?

This study investigated a novel mechanism by which Candida albicans facilitates the invasion and systemic dissemination of Staphylococcus aureus through mucosal tissue. Specifically, the concept of Candida albicans Staphylococcus aureus ‘hitchhiking’ was examined, where researchers explored whether S. aureus can adhere to the invasive hyphal form of C. albicans via specific adhesin interactions, enabling it to bypass the need for a traditional epithelial breach. Key attention was given to the role of the C. albicans Als3p adhesin in mediating this “microbial hitchhiking,” allowing S. aureus to bind to fungal hyphae, penetrate tissue, and cause systemic disease. This hypothesis was tested through in vitro biofilm assays, ex vivo tongue models, and a murine model of oral co-colonization.

Who was studied?

The study used in vitro dual-species biofilm models, ex vivo murine tongue tissue, and immunosuppressed C57BL/6J mice. Multiple strains of S. aureus, including USA300 JE2 wild-type and 25 adhesin-deficient mutants, were tested for their binding ability to C. albicans hyphae. The fungal strains included C. albicans SC5314 wild-type, an Als3p-deficient mutant (als3Δ/Δ), and an Als3p-complemented strain. These models enabled evaluation of microbial binding, tissue invasion, and systemic dissemination under conditions mimicking human mucosal colonization in immunocompromised hosts.

Most important findings

The researchers found that S. aureus specifically binds to the hyphal form of C. albicans via the fungal Als3p adhesin. This interaction is essential for bacterial invasion across the mucosal barrier and subsequent dissemination. In vitro and real-time microscopy confirmed that S. aureus rapidly attaches to C. albicans hyphae. In the murine model, systemic infection and mortality occurred only when mice were co-colonized with S. aureus and Als3p-expressing C. albicans. Mice co-infected with the Als3p-deficient mutant showed no dissemination or mortality. Recovery of S. aureus and C. albicans from kidney tissue was only observed in mice infected with strains expressing Als3p. Additionally, three S. aureus adhesin mutants (ΔfnbB, ΔsasF, Δatl) showed significantly reduced hyphal binding, but no single staphylococcal adhesin was solely responsible, implying redundancy in adhesin interactions.

Tissue SiteOrganism Recovered Only with Als3p
TongueS. aureus colonization enhanced by C. albicans presence regardless of Als3p
KidneyS. aureus and C. albicans only recovered if Als3p was expressed

Key implications

This study introduces a paradigm-shifting concept in microbial pathogenesis: fungal-mediated bacterial invasion through mucosal surfaces. The discovery that C. albicans hyphae can serve as conduits for systemic S. aureus infection has profound clinical implications, particularly in immunocompromised patients where these microbes frequently co-colonize mucosal surfaces. This work identifies Als3p as a critical target for disrupting this pathogenic synergy, suggesting that Als3p or C. albicans inhibition may serve as a preventive strategy against invasive staphylococcal infections. The findings also underscore the need to screen for C. albicans colonization in critically ill patients as a risk factor for secondary bacterial sepsis.

Staphylococcus aureus (S. Aureus)

Staphylococcus aureus is a versatile skin and mucosal commensal that can transition into a highly virulent pathobiont. Known for its immune-evasive strategies, toxin production, and antibiotic resistance, it plays a significant role in chronic infections and microbiome imbalance.

Staphylococcus aureus (S. Aureus)

Staphylococcus aureus is a versatile skin and mucosal commensal that can transition into a highly virulent pathobiont. Known for its immune-evasive strategies, toxin production, and antibiotic resistance, it plays a significant role in chronic infections and microbiome imbalance.

Staphylococcus aureus (S. Aureus)

Staphylococcus aureus is a versatile skin and mucosal commensal that can transition into a highly virulent pathobiont. Known for its immune-evasive strategies, toxin production, and antibiotic resistance, it plays a significant role in chronic infections and microbiome imbalance.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.